Cure Rare Disease Inc
Cure Rare Disease Inc's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $174,441 for Richard Horgan, Founder & Ceo (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $179,031. It is higher than the D + F figure for 99 of 206 peer organizations selected under the disclosed tier Same NTEE major group (G), nationwide + size band 0.71–1.4× revenue (approximately 48%; median $184,934). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Cure Rare Disease Inc, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (G), nationwide + size band 0.71–1.4× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Transplant Foundation | PA | $4,453,241 | $430,161 |
| The International Waldenstrom's | FL | $4,463,374 | $166,197 |
| Northland Cares | AZ | $4,474,851 | $84,864 |
| Massachusetts Health Officers | MA | $4,384,699 | $136,366 |
| Sunrise Community Of Southwest Florida | FL | $4,364,175 | $29,950 |
| National Certification Commission For | VA | $4,515,548 | $323,919 |
| National Cancer Center Inc | NY | $4,354,189 | $135,581 |
| Activating Change Inc | OH | $4,350,932 | $287,519 |
View the organization record and available filings on ProPublica